Latest "Coalition Cure Prostate Cancer" News Stories

14:15 EDT 16th July 2018 | BioPortfolio

Here are the most relevant search results for "Coalition Cure Prostate Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Coalition Cure Prostate Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Coalition Cure Prostate Cancer for you to read. Along with our medical data and news we also list Coalition Cure Prostate Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Coalition Cure Prostate Cancer Companies for you to search.

Showing "Coalition Cure Prostate Cancer" News Articles 1–25 of 16,000+

Extremely Relevant

Could Prostate Cancer Be Treated with Aromatherapy in the Future?

Treating prostate cancer could one day be as noninvasive as inhaling certain scented compounds. The idea may not be as far-fetched as it sounds given that new research from investigators at Duke University School of Medicine shows that an olfactory receptor plays a critical role in the progression of prostate cancer. The researchers found that activating an olfactory receptor called OR51E2 in pros...

His Prostate Cancer Becomes Her Struggle, Too

FRIDAY, March 23, 2018 -- Difficulties tied to prostate cancer may not be limited to men. Many wives of men with advanced prostate cancer say their husband's illness has harmed their own health, a new study finds. "Many prostate cancer patients have...

What Might Make Prostate Cancer's Return More Likely?

FRIDAY, Jan. 26, 2018 -- Obesity and other health problems may boost the chances of cancer returning after a man has his prostate removed, a new study finds. "Prostate cancer is the most common cancer in men, and up to 30 percent of patients will...


Medical News Today: Can women get prostate cancer?

Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.

Liquid biopsy technology to improve prostate cancer treatment

Prostate cancer is the second most common cancer in men and the fifth leading cause of death from cancer in men worldwide, according to 2012 numbers. While several viable treatment options for prostate cancer exist, many men affected with prostate cancer will not respond to first-line treatments. Researchers have now developed a new technology for liquid biopsy to identify which patients may not r...

The Case for Platinum Therapy in Prostate Cancer

The arsenal of therapeutic options for men with castration-resistant prostate cancer has steadily grown as ongoing research uncovers more about prostate cancer biology and resistance mechanisms. 

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

Prostate tumours tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumours metastasize, the disease is invariably...

Prostate Cancer Risk Prediction Improved by DNA Test Sensitive to New Gene Variants

New testing strategies for prostate cancer, including noninvasive saliva tests, may be close to hand, now that an in-depth study of DNA samples from more than 140,000 men has implicated 63 additional genetic variants in prostate cancer risk. By adding the newfound variants to previously known prostate cancer risk variants, scientists based at the Institute of Cancer Research (ICR), London, have de...

‘Prostate cancer is now a bigger killer than breast cancer’ – Independent Online

Independent Online'Prostate cancer is now a bigger killer than breast cancer'Independent OnlineA technician looks at images from an ultrasound machine that helps doctors to diagnose and guide treatment of prostate cancer. Picture: AP. Gary Pettit considers himself to be one of the fortunate ones. Six years ago he was offered a private medical ...This is the real reason more men are dying of prosta...

Does single PSA test have effect on prostate cancer detection, death?

(JAMA Network) A screening program that invited men to a clinic to undergo a single prostate-specific antigen (PSA) test increased detection of low-risk prostate cancer but made no significant difference in prostate cancer deaths after 10 years.

Immunotherapy for Prostate Cancer: Where Do We Go From Here?—PART 1: Prostate Cancer Vaccines

The first article in this two-part series will provide an overview of both past and present therapeutic vaccination strategies for the promotion of antitumor immunity against prostate cancer.

One-off PSA screening for prostate cancer does not save lives

(Cancer Research UK) Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial conducted over 10 years by Cancer Research UK-funded scientists and published today (Tuesday) in JAMA.

Immunotherapy could stop prostate cancer spreading, trial shows – The Guardian

The GuardianImmunotherapy could stop prostate cancer spreading, trial showsThe GuardianMen with otherwise untreatable prostate cancer could halt its spread and survive longer by undergoing immunotherapy treatment, a trial has shown. More than a third of men with an advanced form of the cancer were still alive and one-in-10 had not seen ...Prostate cancer breakthrough as new drug keeps men with pre...

Polygenic Score Predicts Prostate Cancer Development

Currently, detection of prostate cancer relies primarily upon the prostate-specific antigen (PSA) screening blood test, but PSA testing is not...

Blacks With Prostate Cancer May Fare Better Than Whites

FRIDAY, June 1, 2018 -- Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests. Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for...

Smell receptor fuels prostate cancer progression

(Duke University) Researchers have found that an olfactory receptor plays a critical role in the progression of prostate cancer. They found that activating the receptor -- called OR51E2 -- in prostate cancer cells caused the cancer to morph into the more aggressive, castration-resistant form of the disease. The finding suggests that taking the opposite approach -- blocking the receptor with specif...

FDA Approves Apalutamide for Nonmetastatic Prostate Cancer

This is the first approved therapy for prostate cancer patients who have nonmetastatic, castration-resistant prostate cancer. FDA Approvals

Landmark study links tumour evolution to prostate cancer severity

Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has...

May announces £75m prostate cancer boost

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. In February it was announced that it had overtaken breast cancer as the third biggest killer in cancer and just yesterday it was revealed that 40% of prostate cancers are diagnosed late, at which point treatment becomes increasingly difficult. Image caption:  ...

Keytruda offers significant hope in subset of prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at ASCO, a team from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust were able to use MSD’s Keytruda to good effect in 38% of men. There were 258 men on the study for the treatment of advanced prostate cancer and 38% of those were still al...

Advanced Prostate Cancer Variant More Common Than Thought

WEDNESDAY, July 11, 2018 -- The incidence of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) is 17 percent among patients with metastatic castration-resistant prostate cancer (mCRPC), and many t-SCNC biopsy specimens have...

CANCER de la PROSTATE : 150 gènes de susceptibilité pour 30% du risque génétique

À l'heure actuelle, la seule façon de dépister le cancer de la prostate est le test sanguin PSA (Prostate Specific Antigen). Malheureusement, les niveaux de PSA peuvent être augmentés pour d’autres raisons qu’un cancer de la prostate. Le test PSA peut ainsi « laisser passer » certains patients atteints de la maladie, mais peut également conduire à […]

Prostate cancer symptoms: Is the disease terminal? – cancer symptoms: Is the disease terminal? cancer is the most common cancer affecting men, and it kills more than 11,250 men each year. Here are the risk factor you should be aware of. Play slideshow. Prostate cancer - Here are the risk factors you should be aware of. Getty. 1 of 9 ...Thousands of men battling prostate cancer DENIED 'game-changing' drugThe...

Prostate cancer victims denied ‘game-changing’ drug – cancer victims denied 'game-changing' with advanced prostate cancer will be refused a “game-changing” drug on the NHS, after a ruling by rationing watchdogs. Cancer experts said the decision would affect thousands of men who hoped to be able to access the treatment, which has far fewer ...Prostate cancer symptoms: Is the disease terminal? What to ...

Landmark study links tumor evolution to prostate cancer severity

(Ontario Institute for Cancer Research) Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumor has evolved. This information can be used to determine what type and how much treatment should be given to each pat...

Quick Search


News Quicklinks